These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21846439)

  • 21. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
    Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
    Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Chamomile Vaginal Gel on the Sexual Function in Postmenopausal Women: A Double-Blind Randomized Controlled Trial.
    Bosak Z; Iravani M; Moghimipour E; Haghighizadeh MH; Jelodarian P
    J Sex Med; 2022 Jun; 19(6):983-994. PubMed ID: 35400624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Glycine max (L.) Merr. soy isoflavone vaginal gel on epithelium morphology and estrogen receptor expression in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled trial.
    Lima SM; Bernardo BF; Yamada SS; Reis BF; da Silva GM; Galvão MA
    Maturitas; 2014 Jul; 78(3):205-11. PubMed ID: 24856055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial.
    Vaccaro CM; Mutema GK; Fellner AN; Crisp CC; Estanol MV; Kleeman SD; Pauls RN
    Female Pelvic Med Reconstr Surg; 2013; 19(1):34-9. PubMed ID: 23321657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Local Estrogen Cream on Vaginal Health after Pessary Use for Prolapsed Pelvic Organ: A Randomized Controlled Trial.
    Tontivuthikul P; Sanmee U; Wongtra-Ngan S; Pongnarisorn C
    J Med Assoc Thai; 2016 Jul; 99(7):757-63. PubMed ID: 29901374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.
    Dizavandi FR; Ghazanfarpour M; Roozbeh N; Kargarfard L; Khadivzadeh T; Dashti S
    Post Reprod Health; 2019 Mar; 25(1):11-20. PubMed ID: 30786797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial.
    Poordast T; Ghaedian L; Ghaedian L; Najib FS; Alipour S; Hosseinzadeh M; Vardanjani HM; Salehi A; Hosseinimehr SJ
    J Ethnopharmacol; 2021 Apr; 270():113760. PubMed ID: 33383112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial.
    Rahn DD; Good MM; Roshanravan SM; Shi H; Schaffer JI; Singh RJ; Word RA
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3728-36. PubMed ID: 24947034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.
    Loprinzi CL; Abu-Ghazaleh S; Sloan JA; vanHaelst-Pisani C; Hammer AM; Rowland KM; Law M; Windschitl HE; Kaur JS; Ellison N
    J Clin Oncol; 1997 Mar; 15(3):969-73. PubMed ID: 9060535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy.
    Portman DJ; Bachmann GA; Simon JA;
    Menopause; 2013 Jun; 20(6):623-30. PubMed ID: 23361170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review and meta-analysis of the effects of treatment modalities for vestibulodynia in women.
    Pérez-López FR; Bueno-Notivol J; Hernandez AV; Vieira-Baptista P; Preti M; Bornstein J
    Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):337-346. PubMed ID: 31364893
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women.
    Luengratsameerung S; Panyakhamlerd K; Treratanachat S; Taechakraichana N
    Climacteric; 2013 Feb; 16(1):133-40. PubMed ID: 22515801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial.
    Abedi P; Najafian M; Yaralizadeh M; Namjoyan F
    J Med Life; 2018; 11(1):24-28. PubMed ID: 29696061
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaginal estrogens for the treatment of dyspareunia.
    Krychman ML
    J Sex Med; 2011 Mar; 8(3):666-74. PubMed ID: 21091878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Climacteric syndrome: comparison of several secondary therapies].
    Bianco V; Colombo A; Tassan Simonat P
    Ann Ostet Ginecol Med Perinat; 1991; 112(1):54-60. PubMed ID: 1929099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of a plant-based, multi-component cream (Ginetrox®) in vulvovaginal disorders of the genitourinary syndrome during menopause.
    Marrai R; Lissi G; Togni S; Maramaldi G; Barbara M; Giacomelli L
    Minerva Ginecol; 2017 Jun; 69(3):245-249. PubMed ID: 28420227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women: A Randomized Clinical Trial.
    Ferrante KL; Wasenda EJ; Jung CE; Adams-Piper ER; Lukacz ES
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):112-117. PubMed ID: 31232721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.
    Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN
    Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream.
    Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE
    Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.